scs-2019

Industry talk: Dr. Fabian Birzele

We are proud to announce Dr. Fabian Birzele as a keynote speaker of the SCS 2019!

Fabian Birzele studied Bioinformatics in Munich and holds a PhD in Bioinformatics from the LMU in Munich that he completed in 2009 in the group of Ralf Zimmer. After his PhD he moved to a PostDoc at Boehringer Ingelheim implementing NGS technologies in drug research. In 2011 he joined Roche in Penzberg as bioinformatician working mostly on Oncology projects before he became a group leader for Oncology Bioinformatics in Basel in 2016. Today he is the head of a team of 30 bioinformaticians and biostatisticians called Bioinformatics and Exploratory Data Analysis (BEDA) who support drug development projects across different disease indications from very early stages (target identification and target assessment) down to clinical phase 2 in Roche's Early Research and Development organization (pRED).

Tags: 

Abstract call deadline extended

The 15th ISCB Student Council Symposium Organizing Team is delighted to announce the deadline extension of the Call for Abstracts to May 13, 2019 at 11.59 pm (GMT). All participants who have submitted an abstract to the SCS are eligible to apply to travel fellowships. The deadline for submitting the travel fellowship application is also on the 13th of May!!!

Tags: 

Second keynote announced: Dr. Barbara Treutlein

We are proud to announce Dr. Barbara Treutlein as a keynote speaker of the SCS 2019!

Dr. Barbara Treutlein is a Max Planck Research Group Leader, a Tenure-Track Assistant Professor at the Technical University Munich, and an Associate Professor at the Department of Biosystems Science and Engineering of ETH Zürich. She is being awarded the 2019 ISSCR Dr. Susan Lim Award for Outstanding Young Investigator, due to her outstanding work in single-cell transcriptomics.

Dr. Barbara’s group uses and develops single-cell genomics approaches in combination with stem cell-based 2- and 3-dimensional culture systems to study human organogenesis in health and disease. In particular, they use stem cell-derived human organoids to model the development of human organs in vitro and to understand how cell fate is orchestrated in complex human tissues. Thus, she was one of the first to reconstruct the development of complex mammalian tissue, and to provide a molecular description of individual cell regeneration in the axolotl limb.

Tags: 

Pages

Subscribe to RSS - scs-2019